December 02, 2022
During the Investors Forum 12 young companies had the opportunity to present their company to interesting partners and discuss their business strategy, technology direction and capital-raising plan. On stage of the 18th edition of the Dutch Life Sciences Conference, Spatium Medical became the proud winner of the Investors Forum Prize and was awarded a partnering ticket, national or international, with a total value of €2,500.
December 02, 2022
The winner of the Venture Challenge was announced at the Dutch Life Sciences Conference. The proud winner of the 2022 spring edition is PrecorDx! The innovative startup PrecorDx has developed a non-invasive diagnostic platform aimed at reducing hospitalization & slowing disease progression in heart failure.
December 01, 2022
Take a look at which presentations are available to be downloaded.
November 10, 2022
River BioMedics was founded on a novel, human iPSC-derived, 3D cardiac strip platform which represents human heart function, in an in vitro setting. The technology allows direct effects on human cardiac tissue of modification of drug target activity, to be measured at the very beginning of the drug discovery process. River exploits this in-house technology to validate novel cardiac drug discovery targets, identified from human genome wide association studies (GWAS) in heart failure.
November 09, 2022
How to get reimbursement for your healthcare innovations
“Will my device or therapy get reimbursed?” has become critical, even for early development stage life sciences companies. From early investment rounds, investors want assurance of a return on their investment, and while they may not expect start-up companies to have all the reimbursement answers, they do expect companies to have identified the correct reimbursement questions.
November 09, 2022
Ceradis has a sustainable mission: to enable farmers to produce food in a way that is safer for people and better for the environment. The company develops biological alternatives to protect crops. For years, V.O. has been the strategic partner in building their patent portfolio that is critical to their commercial success.
November 02, 2022
Digital health is on the rise, but what is digital health exactly? In this blog post from our partner QbD, we'll explore the landscape, key technology pillars and future opportunities.
‘Digital health‘ is on the rise. It’s a term we use more and more often. But what is digital health? What does it mean? After some research, we find all kinds of definitions… It’s still a jungle out there.
Not to worry though: at the QbD Group, we strive to be at the forefront of innovation and share our latest insights and knowledge with you. In this particular blog post, we want to:
November 02, 2022
Are you a researcher in the life sciences and are you looking to turn your research into a viable product or service that helps patients, physicians or other researchers? Make sure you give your start-up company the best possible start by joining the lifesciences@work Venture Challenge.